Magnaspartate

Magnesium, the active ingredient in Magnaspartate, is a mineral supplement presented as an oral dietary product for oral use. It treats magnesium deficiency and supports normal muscle, nerve and cardiovascular function.

GNH USA supplies Magnaspartate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnaspartate provides magnesium to address conditions related to low magnesium status and associated muscular and neurological function. - Magnesium deficiency: restores normal magnesium levels and helps prevent related symptoms. - Muscle cramps: reduces frequency and intensity of occasional cramp episodes. - Normal muscle and nerve function: supports physiological nerve transmission and muscle contraction.

Magnaspartate is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after ingestion. - Nausea: feeling of queasiness or urge to vomit. - Abdominal cramping: mild to moderate stomach discomfort. - Headache: transient head pain without other neurological signs.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium that can affect heart rhythm. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring emergency care. - Cardiac arrhythmia: irregular heartbeat potentially linked to excess magnesium.

Magnaspartate should be used with attention to specific health conditions and proper storage. - Renal impairment: adjust dose or monitor serum magnesium closely. - Existing hypermagnesemia: avoid use to prevent toxicity. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Concomitant electrolyte disorders: monitor potassium and calcium levels. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Magnaspartate can affect the absorption or action of several medicines.

Major Interactions (Avoid): - Loop diuretics: increase urinary magnesium loss, reducing effectiveness. - Bisphosphonates: magnesium may decrease drug absorption if taken together. - Antacids containing aluminum or calcium: form insoluble complexes that lower magnesium uptake.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may contribute to reduced magnesium levels over time. - Tetracycline antibiotics: chelation can lower both magnesium and antibiotic absorption. - Cardiac glycosides (e.g., digoxin): monitor for signs of hypermagnesemia which can potentiate cardiac effects.